[Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis]

MeSH terms

• Anti-Infective Agents / adverse effects
• Anti-Infective Agents / therapeutic use*
• Consumer Product Safety*
• Humans
• Practice Guidelines as Topic
• Protein C / adverse effects*
• Protein C / therapeutic use*
• Recombinant Proteins / adverse effects
• Recombinant Proteins / therapeutic use
• Sepsis / drug therapy*
• Sepsis / mortality
• Treatment Outcome